OBJECTIVE: This study compared demographic, clinical and laboratory characteristics between patients with radiographic and non-radiographic axial spondyloarthritis (axSpA). METHODS: In this single-centre cross-sectional study, a total of 246 patients with axSpA fulfilling the imaging arm of Assessment of SpondyloArthritis International Society classification criteria were recruited. A total of 140 patients were diagnosed as non-radiographic axial spondyloarthritis (nr-axSpA), and 106 patients had ankylosing spondylitis (AS). Sociodemographic characteristics, disease manifestations, clinical and laboratory disease activity and their differences between subsets were analysed. P values below 0.05 with CI 95% were considered statistically significant. RESULTS: More nr-axSpA patients were women (61.4%) compared with 24.7% of AS patients. First symptoms developed earlier in AS patients compared with nr-axSpA (23.0 (IQR 17.5-30.0) vs 27.8 (IQR 21.0-33.7) years, p=0.001). Disease manifestations did not differ, but patients with nr-axSpA experienced peripheral arthritis more frequently (35.7% vs 17.0%, p=0.001) with less hip involvement (8.6% vs 18.9%, p=0.022) compared with patients with AS. Patients with AS exhibited worse spinal mobility and physical function compared with nr-axSpA. AS Disease Activity Scores and CRP levels were significantly higher in patients with AS compared with nr-axSpA (2.4 (IQR 1.7-2.8) vs 2.0 (IQR 1.1-2.3), p=0.022 and 7.1 (IQR 2.6-14.9) vs 2.5 (IQR 0.8-8.2) mg/L, p<0.001, respectively). CONCLUSIONS: Our data demonstrated some known and also novel differences between the two imaging arm fulfilling axSpA subgroups. Non-radiographic patients were mostly women who had experienced shorter disease duration, milder disease activity and better functional status with less hip involvement but more peripheral arthritis compared with patients with AS.

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Institute of Rheumatology and Department of Rheumatology 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet 2017;390:73–84. 10.1016/S0140-6736(16)31591-4 PubMed DOI

Taurog JD, Chhabra A, Colbert RA. Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 2016;375:2563–74. 10.1056/NEJMra1406182 PubMed DOI

Paramarta JE, Baeten D. Spondyloarthritis: from unifying concepts to improved treatment. Rheumatology 2014;53:1547–59. 10.1093/rheumatology/ket407 PubMed DOI

van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8. PubMed

Dincer U, Cakar E, Kiralp MZ, et al. . Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria. Clin Rheumatol 2008;27:457–62. 10.1007/s10067-007-0727-6 PubMed DOI

Rudwaleit M, van der Heijde D, Landewé R, et al. . The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777–83. 10.1136/ard.2009.108233 PubMed DOI

Poddubnyy D, Sieper J. Radiographic progression in ankylosing spondylitis/axial spondyloarthritis: how fast and how clinically meaningful? Curr Opin Rheumatol 2012;24:363–9. 10.1097/BOR.0b013e328352b7bd PubMed DOI

Poddubnyy D, Sieper J. Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol 2014;26:377–83. 10.1097/BOR.0000000000000071 PubMed DOI

Kiltz U, Baraliakos X, Karakostas P, et al. . Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res 2012;64:1415–22. 10.1002/acr.21688 PubMed DOI

Rudwaleit M, Haibel H, Baraliakos X, et al. . The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717–27. 10.1002/art.24483 PubMed DOI

Baraliakos X, Braun J. Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD Open 2015;1:e000053 10.1136/rmdopen-2015-000053 PubMed DOI PMC

de Winter JJ, van Mens LJ, van der Heijde D, et al. . Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther 2016;18:196 10.1186/s13075-016-1093-z PubMed DOI PMC

Rudwaleit M, Braun J, Sieper J. [ASAS classification criteria for axial spondyloarthritis]. Z Rheumatol 2009;68:591–3. 10.1007/s00393-009-0510-y PubMed DOI

Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. . Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003;62:127–32. 10.1136/ard.62.2.127 PubMed DOI PMC

Lukas C, Landewé R, Sieper J, et al. . Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18–24. 10.1136/ard.2008.094870 PubMed DOI

Garrett S, Jenkinson T, Kennedy LG, et al. . A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 1994;21:2286–91. PubMed

Jones SD, Calin A, Steiner A. An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach’s alpha scores. J Rheumatol 1996;23:407. PubMed

Bennett PH BT. Population studies of the rheumatic diseases. Amsterdam: Excerpta Medica Foundation, 1968.

Wanders AJ, Landewé RB, Spoorenberg A, et al. . What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 2004;50:2622–32. 10.1002/art.20446 PubMed DOI

Jeong H, Yoon JY, Park EJ, et al. . Clinical characteristics of nonradiographic axial spondyloarthritis in Korea: a comparison with ankylosing spondylitis. Int J Rheum Dis 2015;18:661–8. 10.1111/1756-185X.12458 PubMed DOI

Wallis D, Haroon N, Ayearst R, et al. . Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? J Rheumatol 2013;40:2038–41. 10.3899/jrheum.130588 PubMed DOI

Lee W, Reveille JD, Davis JC, et al. . Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 2007;66:633–8. 10.1136/ard.2006.060293 PubMed DOI PMC

Amor B, Santos RS, Nahal R, et al. . Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol 1994;21:1883–7. PubMed

Pradeep DJ, Keat A, Gaffney K. Predicting outcome in ankylosing spondylitis. Rheumatology 2008;47:942–5. 10.1093/rheumatology/ken195 PubMed DOI

Carter N, Williamson L, Kennedy LG, et al. . Susceptibility to ankylosing spondylitis. Rheumatology 2000;39:445 10.1093/rheumatology/39.4.445 PubMed DOI

Turina MC, de Winter JJ, Paramarta JE, et al. . Clinical and Imaging Signs of Spondyloarthritis in First-Degree Relatives of HLA-B27-Positive Ankylosing Spondylitis Patients: The Pre-Spondyloarthritis (Pre-SpA) Cohort Study. Arthritis Rheumatol 2016;68:2444–55. 10.1002/art.39766 PubMed DOI

de Carvalho HM, Bortoluzzo AB, Gonçalves CR, et al. . Gender characterization in a large series of Brazilian patients with spondyloarthritis. Clin Rheumatol 2012;31:687–95. 10.1007/s10067-011-1890-3 PubMed DOI

Will R, Edmunds L, Elswood J, et al. . Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol 1990;17:1649–52. PubMed

Dernis E, Said-Nahal R, D’Agostino MA, et al. . Recurrence of spondylarthropathy among first-degree relatives of patients: a systematic cross-sectional study. Ann Rheum Dis 2009;68:502–7. 10.1136/ard.2008.089599 PubMed DOI

Wallman JK, Kapetanovic MC, Petersson IF, et al. . Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients-baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice. Arthritis Res Ther 2015;17:378 10.1186/s13075-015-0897-6 PubMed DOI PMC

Vander Cruyssen B, Vastesaeger N, Collantes-Estévez E. Hip disease in ankylosing spondylitis. Curr Opin Rheumatol 2013;25:448–54. 10.1097/BOR.0b013e3283620e04 PubMed DOI

Deciphering miRNA signatures in axial spondyloarthritis: The link between miRNA-1-3p and pro-inflammatory cytokines

Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis